Pharmaceutical

Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031

The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over the course of the forecast period.

Aug 24, 2023 - 20:00
Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031
The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over the course of the forecast period.
Read the original article

Tags:

Previous Article

SK Bioscience and Vaxxas partner to develop needle-free typhoid vaccine patch

Next Article

UK life sciences grapple with the job market’s digital dilemma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AGC Biologics and the Jikei University partner for IPF project

AGC Biologics and the Jikei University partner for IPF ...

Apr 4, 2023

Hoth and Aronnax partner for HT-KIT cancer therapy development

Hoth and Aronnax partner for HT-KIT cancer therapy deve...

Aug 17, 2024

STAT+: Medical device maker Teleflex to acquire urology company Palette Life Sciences for $600 million

STAT+: Medical device maker Teleflex to acquire urology...

Jul 26, 2023